Which is the best primary medication for long-term smoking cessation - Nicotine replacement therapy, bupropion or varenicline

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 17, 2007, Pages 2903-2915

  Doggrell, Sheila A ^a  

^a Doggrell Biomedical Communications   (Australia)

Author keywords

Bupropion; Nicotine replacement therapy; Smoking cessation; Varenicline

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NON PRESCRIPTION DRUG; PLACEBO; VARENICLINE;

APPLICATION SITE REACTION; ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CORONARY ARTERY DISEASE; COUGHING; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPEPSIA; EDEMA; ERYTHEMA; FEMALE; GASTRITIS; GASTROINTESTINAL TOXICITY; GENDER; GROUP THERAPY; HEARTBURN; HICCUP; HUMAN; INDIGESTION; INHALER; INSOMNIA; LONG TERM CARE; LOW DRUG DOSE; LOZENGE; LUNG DISEASE; MALE; MONOTHERAPY; MOUTH DISCOMFORT; NAUSEA; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PATIENT COUNSELING; RELAPSE; SEIZURE; SHORT COURSE THERAPY; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; STOMACH PAIN; SUBCAPSULAR CATARACT; THROAT IRRITATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREATMENT DURATION; TREMOR; UNPLEASANT DREAM; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

BENZAZEPINES; BUPROPION; COMBINED MODALITY THERAPY; COUNSELING; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION ROUTES; DRUG PARTIAL AGONISM; DRUG THERAPY, COMBINATION; HUMANS; NICOTINE; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 37349095296     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.17.2903     Document Type: Article

References (85)

1. HENNINGFIELD JE, GRIFFITHS RR: Effects of ventilated cigarette holders on cigarette smoking by humans. Psychopharmacology (Berl.) (1980) 68:115-119.
2. DI MATTEO V, PIERUCCI M, DI GIOVANNI G, BENIGNO A, ESPOSITO: The neurobiological bases for the pharmacotherapy of nicotine addiction. Curr. Pharm. Des. (2007) 13:1269-1284.
3. MCNABB ME, EBERT RV, MCCUSKER K: Plasma nicotine levels produced by chewing nicotine gum. JAMA (1982) 248:865-868.
4. MCNABB ME: Chewing nicotine gum for 3 months. What happens to plasma nicotine levels? Can. Med. Ass. J. (1984) 131:589-592.
5. JARVIS MJ, RAW M, RUSSEL MAH: Randomised controlled trial of nicotine chewing gum. Br. Med. J. (1982) 285:537-540.
6. TONNESEN P, FRYD V, HANSEN M et al.: Effect of nicotine chewing gum in combination with group counselling an the cessation of smoking. N. Engl. J. Med. (1988) 318:15-18.
7. SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (2002) (4):CD000146.
8. FORTMANN SP, KILLEN JD, TELCH MJ, NEWMAN B: Minimal contact treatment for smoking cessation: a placebo-controlled trial of nicotine polcrilex and self-directed relapse prevention: initial results of the Stanford Stop Smoking Project. JAMA (1988) 260:1575-1580.
9. KILLEN JD, FORTMANN SP, NEWMAN B: Weight change among participants in a large sample minimal contact smoking relapse prevention trial. Addict. Behav. (1990) 15:323-332.
10. WENNIKE P, DANIELSSON T, LANDFELDT B, WESTIN A, TONNESEN P: Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow up. Addiction (2003) 98:1395-1402.
11. DAUGHTON DM, HEATLEY SA, PRENDERGAST JJ et al.: Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch. Intern. Med. (1991) 151:749-752.
12. TONNESEN P, NORREGAARD J, SIMONSEN K, SAWE U: A double blind trial of a 16-h transdermal nicotine patch in smoking cessation. N. Engl. J. Med. (1991) 325:311-315.
13. RUSSELL MA, STAPLETON JA, PEYERABEND C et al.: Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ (1993) 306:1308-1312.
14. HURT RD, DALE LC, FREDRICKSON PA et al.: Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA (1994) 271:595-600.
15. GOURLAY SG, FORBES A, MARRINER T, PETHICA D, MCNEIL JJ: Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ (1995) 311:363-366.
16. TRANSDERMAL NICOTINE STUDY GROUP: Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA (1991) 266:3133-3138.
17. SACHS DPL, SAWE U, LEISCHOW SJ: Effectiveness of a 16-h transdermal nicotine patch in a medical practice setting, without intensive group counselling. Arch. Intern. Med. (1993) 153:1881-1890.
18. JORENBY DE, SMITH SS, FIORE MC et al.: Varying nicotine patch dose and type of smoking cessation counselling. JAMA (1995) 274:1347-1352.
19. DAVIDSON M, EPSTEIN M, BURT R et al.: Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch. Fam. Med. (1998) 7:569-574.
20. SHIFFMAN S, DRESLER CM, HAJEK P et al.: Efficacy of a nicotine lozenge for smoking cessation. Arch. Intern. Med. (2002) 162:1267-1276.
21. SHIFFMAN S, DRESLER CM, ROHAY JM: Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction (2004) 99:83-92.
22. SUTHERLAND G, STAPLETON JA, RUSSELL MA et al.: Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet (1992) 340:324-329.
23. HJALMARSON A, FRANZON M, WESTIN A, WIKLUND O: Effect of nicotine nasal spray on smoking cessation. A randomized, placebo-controlled, double-blind study. Arch. Intern. Med. (1994) 154:2567-2572.
24. BLONDAL T, FRANZON M, WESTIN A: A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur. Respir. J. (1997) 10:1585-1590.
25. BLONDAL T, GUDMUNDSSON LJ, OLAFSDOTTIR I, GUSTAVSSON G, WESTIN A: Nicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow up. BMJ (1999) 318:285-288.
26. CROGHAN GA, SLOAN JA, CROGHAN IT et al.: Comparison of nicotine patch alone versus nicotine nasal spray versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob. Res. (2003) 5:181-187.
27. SCHNEIDER NG, OLMSTEAD RE, FRANZON MA, LUNELL E: The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin. Pharmacokinet. (2001) 40:661-684.
28. TONNESEN P, NORREGAARD J, MIKKELSEN K, JORGENSEN S, NILSSON F: A double-blind trial of a nicotine inhaler for smoking cessation. JAMA (1993) 269:1268-1271.
29. HJALMARSON A, NILSSON F, SJOSTROM L, WIKLUND O: The nicotine inhaler in smoking cessation. Arch. Intern. Med. (1997) 157:1721-1728.
30. LEISCHOW SJ, RANGER-MOORE J, MURAMOTO ML, MATTHEWS E. Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. Am. J. Health Behav. (2004) 28:291-301.
31. HUGHES JR, ADAMS EH, FRANZON MA, MAGUIRE MK, GUARY Y: A prospective study of off-label use of, abuse of, and dependence on nicotine inhaler. Tob. Control (2005) 14:49-54.
32. BOHADANA A, NILSSON F, RASMUSSEN T, MARTINET Y: Nicotine inhaler and nicotine patch as a combination for smoking cessation - a randomised, double-blind, placebo-controlled trial. Arch. Intern. Med. (2000) 160:3128-3134.
33. TONNESEN P, MIKKELSEN KL: Smoking cessation with four nicotine replacement regimes in a lung clinic. Eur. Respir. J. (2000) 16:717-721.
34. WALLSTROM M, NILSSON F, HIRSCH JM: A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction (2000) 95:1161-1171.
35. GLOVER ED, GLOVER PN, FRANZON M et al.: A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine Tob. Res. (2002) 4:441-450.
36. TANG JL, LAW M, WALD N: How effective is nicotine replacement therapy in helping people to stop smoking? BMJ (1994) 343:139-142.
37. SILAGY C, MANT D, FOWLER G, LODGE M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet (1994) 343:139-142.
38. FIORE MC, SMITH SS, JORENBY DE, BAKER TB: The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA (1994) 271:1940-1947.
39. HAJEK P, WEST R, FOULDS J et al.: Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch. Intern. Med. (1999) 159:2033-2038.
40. SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. (2004) (3):CD000146.
41. SCHNEIDER NG, TERRACE S, KOURY MA et al.: Comparison of three nicotine treatments: initial reactions and preference with guided use. Psychopharmacology (Berl.) (2005) 182:545-550.
42. HJALMARSON AL: Effects on nicotine gum in smoking cessation. A randomized, placebo-controlled, double-blind study. JAMA (1984) 252:2835-2838.
43. MURRAY RP, CONNETT JE, RAND CS, PAN W, ANTHONISEN NR: Persistence of the effect of the lung health study (LHS) smoking intervention over eleven years. Prev. Med. (2002) 35:314-319.
44. TONNESEN P, PAOLETTI P, GUSTAVSSON G et al.: Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur. Respir. J. (1999) 13:238-246.
45. MOLYNEUX A, LEWIS S, LEIVERS U et al.: Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax (2003) 58:484-488.
46. TONNESEN P, MIKKELSEN K, BREMANN L: Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest (2006) 130:334-342.
47. STUDY INVESTIGATORS: Nicotine replacement therapy for patients with coronary artery disease. Working group for the study of transdermal nicotine in patients with coronaty artery disease. Arch. Intern. Med. (1994) 154:989-995.
48. LUDVIG J, MINER B, EISENBERG MJ: Smoking cessation in patients with coronary artery disease. Am. Heart J. (2005) 149:565-572.
49. WARNER C, SHOAIB M: How does bupropion work as a smoking cessation aid? Addict. Biol. (2005) 10:219-231.
50. HURT RD, SACHS DP, GLOVER ED et al.: A comparison of sustained-release bupropion and placebo for smoking cessation. N. Engl. J. Med. (1997) 337:1195-1202.
51. HAYFORD KE, PATTEN CA, RUMMANS TA et al.: Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism. Br. J. Psychiatry (1999) 174:173-178.
52. DALE LC, GLOVER ED, SACHS DP et al.: Bupropion for smoking cessation: predictors of successful outcome. Chest (2001) 119:1357-1364.
53. TONNESEN P, TONSTAD S, HJALMARSON A et al.: A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J. Intern. Med. (2003) 254:184-192.
54. HAYS JT, HURT RD, RIGOTTI NA et al.: Sustained-release bupropion for pharmacological relapse after smoking cessation, a randomized, controlled trial. Ann. Intern. Med. (2001) 135:423-433.
55. GONZALES D, BJORNSON W, DUNCAN MJ et al.: Effect of gender on relapse prevention in smokers treated with bupropion SR. Am. J. Prev. Med. (2002) 22:234-239.
56. DURCAN MJ, DEENER G, WHITE J et al.: The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clin. Ther. (2002) 24:540-551.
57. SWAN GE, MCAFEE T, CURRY SJ et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch. Intern. Med. (2003) 163:2337-2344.
58. JORENBY DE, LEISCHOW SJ, NIDES MA et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N. Engl. J. Med. (1999) 340:685-691.
59. JAMERSON BD, NIDES M, JORENBY DE et al.: Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clin. Ther. (2001) 23:744-752.
60. GONZALES DH, NIDES MA, FERRY LH et al.: Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin. Pharmacol. Ther. (2001) 69:438-444.
61. SMITH SS, JORENBY DE, LEISCHOW SJ et al.: Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob. Res. (2003) 5:99-109.
62. SIMON JA, DUNCAN C, CARMODY TP, HUDES ES: Bupropion for smoking cessation: a randomized trial. Arch. Intern. Med. (2004) 164:1797-1803.
63. LEIGH R, VINER NM, COX G et al.: Nicotine replacement combined with a novel compound (ProBan) for smoking cessation: a pilot study. Can. Respir. J. (2001) 8:21-26.
64. CLARK MM, HURT RD, CROGHAN IT et al.: The prevalence of weight concerns in smoking abstinence clinical trial. Addict. Behav. (2006) 31:1144-1152.
65. TASHKIN D, KANNER R, BAILEY W et al.: Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet (2001) 357:1571-1575.
66. TONSTAD S, FARSANT C, KLAENE G et al.: Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur. Heart J. (2003) 24:946-955.
67. AHLUWALIA JS, HARRIS KJ, CATLEY D, OKUYEMI KS, MAYO MS: Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA (2002) 288:468-474.
68. HOLT S, TIMU-PARATA C, RYDER-LEWIS S, WEATHERALL M, BEASLEY R: Efficacy of bupropion in the indigenous Maori population in New Zealand. Thorax (2005) 60:120-123.
69. COLLINS BN, WILEYTO EP, PATITERSON F: Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counselling. Nicotine Tob. Res. (2004) 6:27-37.
70. SCHARF D, SHIFFMAN S: Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction (2004) 99:1462-1469.
71. HURT RD, KROOK JE, CROGHAN IT et al.: Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J. Clin. Oncol. (2003) 21:914-920.
72. FERRY L, JOHNSTON JA: Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience. Int. J. Clin. Pract. (2003) 57:224-230.
73. HUBBARD R, LEWIS S, WEST J et al.: Bupropion and the risk of sudden death: a self-controlled case-series analysis using the health improvement network. Thorax (2005) 60:848-850.
74. 2 nicotinic receptor partial agonist - results from a 7-week, randomized, placebo- and bupropion-controlled trial with a 1-year follow-up. Arch. Intern. Med. (2006) 166:1561-1568.
75. 2 nicotine acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation - a randomized controlled trial. JAMA (2006) 296:47-55.
76. 2 nicotine acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation - a randomized controlled trial. JAMA (2006) 296:56-63.
77. TONSTAD S, TENNESEN P, HAJEK P et al.: Effect of maintenance therapy with varenicline on smoking cessation - a randomized controlled trial. JAMA (2006) 296:64-71.
78. WILLIAMS KE, REEVES KR, BILLING CB Jr, PENNINGTON AM, GONG J: A double-blind study evaluation the long-term safety of varenicline for smoking cessation. Curr. Med. Res. Opin. (2007) 23:793-801.
79. ONCKEN C, GONZALES D, NIDES M et al.: Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch. Intern. Med. (2006) 166:1571-1577.
80. CAHILL K, STEAD LF, LANCASTER T: Nicotine receptor partial agonists for smoking cessation, Cochrane Database Syst. Rev. (2007) 24:CD006103.
81. BOLLIGER CT, VAN BILJON X, AXELSSON A: A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy. Respiration (2007) 74:196-201.
82. KILLEN JD, FORTMAN SP, NEWMAN B, VARDY A: Evaluation of a treatment approach combining nicotine gum with self-guided behavioural treatments for smoking relapse prevention. J. Consult. Clin. Psychol. (1990) 58:85-92.
83. MUNAFO M, BRADBURN M, BOWES L, DAVID S: Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob. Res. (2004) 6:769-776.
84. CEPEDA-BENITO A, REYNOSO JT, ERATH S: Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J. Consult. Clin. Psychol. (2004) 72:712-722.
85. WU P, WILSON K, DIMOULAS P, MILLS EJ: Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health (2006) 6:300.